Get started
Author

Andrey M. Semenov

Observed names: A M Semenov, A. M. Semenov, A.M. Semenov, А М Семенов, А. М. Семенов
ORCID: 0000-0003-1247-4978
Observed ORCID: 0000-0003-1247-4978
OpenAlex ID: A5032955364
Nonimmunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results)
2022 · E.I. Gusev, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 32
Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPE
2024 · Alexander I. Kirienko, Stanislav G. Leontyev, et al. · Journal of Thrombosis and Haemostasis · 16
PDF
Advanced results of Fortelyzin® use in the FRIDOM1 study and real clinical practice
2022 · V. A. Markov, D. V. Duplyakov, et al. · Russian Journal of Cardiology · 15
PDF
Thrombolysis With the Non-Immunogenic Staphylokinase for Acute Ischemic Stroke in the FORPI Registry: An Observational Study
2025 · Nikolay A. Shamalov, Mikhail Yu Martynov, et al. · Stroke · 12
Non-immunogenic staphylokinase — a thrombolytic agent in the treatment of massive pulmonary embolism: results of the FORPE clinical trial
2024 · A. I. Kirienko, S. G. Leontyev, et al. · Russian Journal of Cardiology · 9
PDF
Thrombolytic therapy of ischemic stroke
2018 · E. I. Gusev, M. Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 9
Non-immunogenic staphylokinase in patients with massive intermediate-high risk pulmonary embolism: protocol of the FORPE-2 multicenter, double-blind, randomized, placebo-controlled trial
2025 · S. N. Tereshchenko, E. B. Yarovaya, et al. · Russian Journal of Cardiology · 7
Non-Immunogenic Staphylokinase vs Alteplase in Patients with Massive Pulmonary Embolism: the Protocol of a Multiple-Center Open-Label Randomized Trial FORPE
2022 · A.I. Kirienko, E.B. Yarovaya, et al. · Journal of Venous Disorders · 7
Nebulized Non-Immunogenic Staphylokinase in the Mice Acute Lung Injury Model
2022 · Sergey S. Markin, Roman D. Lapshin, et al. · International Journal of Molecular Sciences · 6
PDF
Safety of prehospital thrombolysis with non-immunogenic staphylokinase in 51021 patients with ST-elevation myocardial infarction: data from the FRIDOM-registry
2025 · S. N. Tereshchenko, S. F. Bagnenko, et al. · Russian Journal of Cardiology · 5
PDF
The Safety of Non‐immunogenic Recombinant Staphylokinase in Elderly Patients With Massive Pulmonary Embolism: A Randomized Clinical Trial FORPE
2025 · Stanislav G. Leontyev, Elena B. Yarovaya, et al. · Health Science Reports · 4
PDF
Fortelyzin in Patients With Acute Myocardial Infarction
2012 · S S Markin, A M Semenov, et al. · Medical academic journal · 4
Safety and efficacy of non-immunogenic staphylokinase in elderly patients over 75 years old with ST-segment elevation myocardial infarction: FREEDOM registry data
2025 · S. N. Tereshchenko, S. F. Bagnenko, et al. · Russian Journal of Cardiology · 3
Intraarterial intrathrombus thrombolysis with non-immunogenic staphylokinase vs surgery in patients with acute limb ischemia: protocol of a multicenter, open-label, randomized clinical trial FORAT
2025 · I.I. Zatevakhin, A.V. Chupin, et al. · Angiology and vascular surgery · 3
Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry
2026 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 2
Prognostic outcome of intravenous thrombolysis with non-immunogenic staphylokinase in patients aged ≥ 60 years with acute ischemic stroke by THRIVE scale
2025 · Nikolay A. Shamalov, Zhanna Yu. Chefranova, et al. · Journal of Thrombosis and Thrombolysis · 2
Fortelyzin in the treatment of minor acute ischemic stroke according to a subanalysis of the observational study FORPI registry
2026 · N. A. Shamalov, M. Yu. Martynov, et al. · Neurology neuropsychiatry Psychosomatics
PDF
Fortelyzin in the treatment of acute ischemic stroke due to basilar-artery occlusion: data from the observational study FORPI registry
2026 · N. A. Shamalov, M. Yu. Martynov, et al. · Neurology neuropsychiatry Psychosomatics
PDF
Local fibrinolysis of hypertensive putaminal hematomas using Fortelyzin
2025 · V. G. Dashyan, A. S. Nikitin, et al. · Russian journal of neurosurgery
PDF
Десятилетний опыт применения лекарственного препарата Фортелизин
2023 · С. С. Маркин, А. М. Семенов, et al. · Экспериментальная и клиническая фармакология
PDF
Pharmacoeconomic Study of Fortolizin® Original Thrombolytic Drug
2013 · S S Markin, Yu B Belousov, et al. · Medical academic journal
Исследование нового отечественного тромболитического препарата Фортелизин® у больных с острым инфарктом миокарда
2012 · С. С. Маркин, А М Семенов, et al. · Сибирский журнал клинической и экспериментальной медицины
Works count: 22
Citation count: 136
H-index: 7
I10-index: 4
Year
Topic
Type